Shopping Cart
- Remove All
- Your shopping cart is currently empty
Onilcamotide, a cancer vaccine derived from the C-terminal peptide of the RhoC protein, exhibits potential immunomodulating and antineoplastic activities.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.444 € | Backorder |
Description | Onilcamotide, a cancer vaccine derived from the C-terminal peptide of the RhoC protein, exhibits potential immunomodulating and antineoplastic activities. |
Molecular Weight | 2293.78 |
Formula | C96H177N39O24S |
Cas No. | 1164096-85-8 |
Relative Density. | no data available |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.